��ѻ��ý

Arturo Casadevall, MD, PhD, and David Sullivan, MD, recommend exploring using convalescent plasma at scale in public health preparedness planning for future disease outbreaks and pandemics. 

Caitlin Rempson's time in the MSPH program has brought her opportunities worldwide, from providing career support to young adults in Baltimore, to researching the intersection of stigma, violence, and depression in youth living with HIV in Zambia. 

As we head into 2025—a year certain to bring great change—we reflect on 2024’s public health headlines.

Michelle Morse, New York City’s acting health commissioner, shares her public health priorities for the residents of the largest city in the U.S.—and how her global health experience influences her work today.

A pediatric infectious disease doctor explains what causes walking pneumonia, how it’s treated, and what parents should know about the recent rise in cases among young children.

The cholera outbreak that swept Zambia in early 2024 highlighted the urgent need for improved water and sanitation infrastructure, especially in urban areas. But the crisis spotlighted another critical factor, too: the stigma surrounding the disease.

Will Garden House Compound, a sprawling maze of makeshift shelters outside Lusaka, Zambia, become a hotspot once again for another deadly cholera outbreak during the upcoming rainy season? 

Powder made from dead cells of soil-dwelling bacterial species also kills mosquitoes resistant to chemical pesticides.

The latest on the virus’s spread, potential economic impacts, vaccine development, and how concerned the general public should be.

DNDi’s Africa Ambassador Monique Wasunna reflects on her efforts to fight neglected diseases and shares insights on the work ahead, including critical needs donors are neglecting.

Almost everyone will get HPV within their lifetime. While many types of HPV go away on their own, others can cause cancer. Fortunately, vaccines can prevent these infections.

The current pipeline for new antibiotics is “on the verge of collapse” within the next four to eight years—and a key reason is that antibiotic makers can’t stay in business.

Rocky Mountain Spotted Fever is a bacterial threat that continues to spread in the Americas because of a lack of research and awareness.

Global Health NOW's coverage from ASMTH's Annual Meeting in New Orleans, Louisiana, November 13–17, 2024—including briefs on mpox, Hansen’s disease, and Rocky Mountain spotted fever, and a walking tour through public health history.